Infermedica scores $10M Series A for its ‘AI-driven’ diagnosis and triage platform

Infermedica, the Poland-founded health tech start-up that offers an AI-driven platform for preliminary diagnosis and triage, has actually raised simply over $10 million in Series A financing. The round is led by the European Bank for Restoration and Advancement (EBRD) and digital health fund Heal Capital. Existing financiers Karma Ventures, Inovo Endeavor Partners and Dreamit Ventures […] The round is led by the European Bank for Reconstruction and Advancement(EBRD )and digital health fund Heal Capital. Infermedica states the investment will be used for platform R&D to even more enhance its patient triage and symptom-checking functions and medical decision support analysis. Founded in 2012 in Wrocław by CEO Piotr Orzechowski, Infermedica explains itself an “AI-driven, customisable, multi-language” platform that aids client care and healthcare service delivery. To that end, current Infermedica clients include health insurance companies, such as Allianz, Global Excel and Medis, where digital triage claims to help optimise healthcare costs. …